Eli Lilly and Company’s investigational drug, retatrutide, a pioneering triple hormone receptor agonist, has demonstrated an average weight loss of…
Read More

Eli Lilly and Company’s investigational drug, retatrutide, a pioneering triple hormone receptor agonist, has demonstrated an average weight loss of…
Read More
Researchers from the Center for Nuclear Energy in Agriculture at the University of São Paulo (CENA-USP) have identified multiple classes…
Read More
Researchers from the Center for Nuclear Energy in Agriculture at the University of São Paulo (CENA-USP) have uncovered a disturbing…
Read More